- Home
- PMEC vs ANVS Comparison
PMEC vs ANVS Comparison
Compare PMEC & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PMEC | ANVS |
|---|---|---|
| Founded | 1984 | 2008 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.0M | 111.3M |
| IPO Year | 2023 | 2020 |
Fundamental Metrics
Financial Performance| Metric | PMEC | ANVS |
|---|---|---|
| Price | $1.06 | $3.95 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $13.50 |
| AVG Volume (30 Days) | 188.8K | ★ 4.0M |
| Earning Date | 01-01-0001 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $74,349,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 2.52 | N/A |
| 52 Week Low | $0.54 | $1.11 |
| 52 Week High | $2.44 | $6.37 |
Technical Indicators
Market Signals| Indicator | PMEC | ANVS |
|---|---|---|
| Relative Strength Index (RSI) | 43.90 | 52.44 |
| Support Level | $0.99 | $4.12 |
| Resistance Level | $1.13 | $4.24 |
| Average True Range (ATR) | 0.06 | 0.47 |
| MACD | 0.03 | -0.15 |
| Stochastic Oscillator | 57.58 | 11.67 |
Price Performance
Historical ComparisonAbout PMEC Primech Holdings Ltd.
Primech Holdings Ltd is a technology-driven facilities services provider in the public and private sectors operating mainly in Singapore. The services offered by the company include Facilities services, Stewarding services, Cleaning services to offices, Cleaning services to homes, and Cleaning Supplies.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.